Rockville, Maryland Saturday, October 5, 2024, 18:00 Hrs [IST] ...
Wayne, Pennsylvania Saturday, October 5, 2024, 17:00 Hrs [IST] ...
Panacell Biotech’s exosome manufacturing method patent registered as original technology: Seoul, South Korea Saturday, October 5, 2024, 16:00 Hrs [IST] Panacell Biotech Co, Ltd.
Recipharm strengthens pharmaceutical development capabilities with strategic investments: Stockholm, Sweden Saturday, October 5, 2024, 15:30 Hrs [IST] Recipharm, a leading global ...
WHO launches global strategic plan to fight rising dengue and other Aedes-borne arboviral diseases: Geneva Saturday, October 5, 2024, 15:00 Hrs [IST] The World Health Organization ...
Bavarian Nordic A/S, a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines, announced an extended commitment to help fight the current mpox outbreak ...
Soligenix partners with Sterling Pharma to optimize and implement a commercially viable, scalable production technology for synthetic hypericin: Princeton, New Jersey Saturday, Oc ...
Shape Therapeutics introduces advances in AI-powered platform for precision RNA editing: Seattle Saturday, October 5, 2024, 13:00 Hrs [IST] Shape Therapeutics, a leader in RNA-bas ...
Halozyme Therapeutics, Inc., a biopharmaceutical company, announced that argenx has nominated four new targets under its global collaboration and license agreement that provides argenx exclusive ...
Daiichi Sankyo submits Enhertu sNDA to Japan’s MHLF for patients with HER2 low or HER2 ultralow metastatic breast cancer: Tokyo Saturday, October 5, 2024, 10:00 Hrs [IST] Daiich ...
WHO approves Abbott Molecular’s mpox diagnostic test, Alinity m MPXV assay for emergency use: Geneva Saturday, October 5, 2024, 09:00 Hrs [IST] The World Health Organization (WH ...
NIMHANS to implement community based programmes to reduce stigma around mental health issues: Nandita Vijayasimha, Bengaluru Saturday, October 5, 2024, 08:00 Hrs [IST] The Karnata ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results